|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-1-19
|
|
pubmed:abstractText |
Although cirrhosis is a major risk factor for development of hepatocellular carcinoma, no definitive prospective analyses have assessed the long-term efficacy of antiviral therapy in cirrhotic patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1539-3704
|
|
pubmed:author |
pubmed-author:ArakawaYasuyukiY,
pubmed-author:HashimotoEtsukoE,
pubmed-author:HirotaKatsutaroK,
pubmed-author:ImazekiFumioF,
pubmed-author:ItoYoichiY,
pubmed-author:NakataRyoR,
pubmed-author:OhashiYasuoY,
pubmed-author:OmataMasaoM,
pubmed-author:ShiratoriYasushiY,
pubmed-author:TanakaNaohideN,
pubmed-author:Tokyo-Chiba Hepatitis Research Group,
pubmed-author:YokosukaOsamuO,
pubmed-author:YoshidaHaruhikoH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
18
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
105-14
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15657158-Antiviral Agents,
pubmed-meshheading:15657158-Carcinoma, Hepatocellular,
pubmed-meshheading:15657158-Cause of Death,
pubmed-meshheading:15657158-Female,
pubmed-meshheading:15657158-Follow-Up Studies,
pubmed-meshheading:15657158-Hepacivirus,
pubmed-meshheading:15657158-Hepatitis C, Chronic,
pubmed-meshheading:15657158-Humans,
pubmed-meshheading:15657158-Interferon-alpha,
pubmed-meshheading:15657158-Liver Cirrhosis,
pubmed-meshheading:15657158-Liver Neoplasms,
pubmed-meshheading:15657158-Male,
pubmed-meshheading:15657158-Middle Aged,
pubmed-meshheading:15657158-Prospective Studies,
pubmed-meshheading:15657158-RNA, Viral,
pubmed-meshheading:15657158-Recombinant Proteins,
pubmed-meshheading:15657158-Risk Factors,
pubmed-meshheading:15657158-Viral Load
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.
|
|
pubmed:affiliation |
University of Tokyo, Japanese Red Cross Medical Center, Nippon University School of Medicine, and Tokyo Women's Medical College. shirato@cc.okayama-u.ac.jp <shirato@cc.okayama-u.ac.jp>
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
